OPT 0.60% 83.5¢ opthea limited

Ann: Opthea Phase 2b wAMD trial fully recruited ahead of schedule, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 17,161 Posts.
    lightbulb Created with Sketch. 2422
    Just goes to show you need to be discerning.

    Lots of investors seem to jump on biotech bandwagons without any real research, medical knowledge or understanding of trials or the industry. MSB and RAP have large "warning" signs all over them IMO. I don't have sympathy at all. They know, or should know, the risks of investing in these companies
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
83.5¢
Change
-0.005(0.60%)
Mkt cap ! $1.027B
Open High Low Value Volume
85.5¢ 85.5¢ 82.0¢ $11.20M 13.42M

Buyers (Bids)

No. Vol. Price($)
1 13018 83.0¢
 

Sellers (Offers)

Price($) Vol. No.
84.0¢ 3897 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.